Muehlbauer Paula M, Schwartzentruber Douglas J
Clinical Center Nursing Department, National Institutes of Health, 9000 Rockville Pike, Bldg 10/Room 7D50/MSC 1664, Bethesda, MD 20892, USA.
Semin Oncol Nurs. 2003 Aug;19(3):206-16. doi: 10.1016/s0749-2081(03)00048-2.
OBJECTIVE: To provide a review of cancer vaccines, how they work, and the current state of the science underlying these treatments. DATA SOURCES: Research studies, review articles, book chapters, personal communications. CONCLUSION: Vaccines have been studied in a variety of malignancies; however, melanoma has provided the best tumor model for vaccination. Clinical trials continue to investigate the optimal vaccine, route, and immunization schedule. IMPLICATIONS FOR NURSING PRACTICE: Oncology nurses must grasp a widening array of therapeutic options for cancer patients. The educational needs of the patient will be better met through a thorough understanding of basic concepts of newer cancer therapies.
目的:综述癌症疫苗、其作用机制以及这些治疗方法背后的科学现状。 数据来源:研究性研究、综述文章、书籍章节、个人交流。 结论:已在多种恶性肿瘤中对疫苗进行了研究;然而,黑色素瘤为疫苗接种提供了最佳肿瘤模型。临床试验继续在探究最佳疫苗、接种途径和免疫方案。 对护理实践的启示:肿瘤护理人员必须掌握越来越多的癌症患者治疗选择。通过深入理解新型癌症治疗的基本概念,能更好地满足患者的教育需求。
Semin Oncol Nurs. 2003-8
Expert Rev Vaccines. 2018-2-8
Semin Oncol Nurs. 2003-8
Nat Rev Immunol. 2003-8
Expert Opin Ther Targets. 2004-12
Clin Dermatol. 2004
Haematologica. 2000-11
Surg Oncol. 2012-4-20
Front Immunol. 2021
Arch Immunol Ther Exp (Warsz). 2015-12